Pediatrix Medical (MD) Free Cash Flow (2009 - 2026)

Pediatrix Medical has disclosed Free Cash Flow across 18 years of filings, most recently posting -$136.1 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 13.95% year-over-year to -$136.1 million; the TTM figure through Mar 2026 stood at $253.0 million (up 11.45% YoY), while the FY2025 annual figure was $269.6 million, up 24.91% from the prior year.
• Free Cash Flow eased to -$136.1 million in Q1 2026, from $125.8 million in the prior quarter.
• Over the last five years, Free Cash Flow for MD reached as high as $152.0 million in Q4 2024 and fell as low as -$136.1 million in Q1 2026.
• The 5-year median for Free Cash Flow is $76.4 million (2022), against an average of $34.7 million.
• Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 32.83% — and 2024, when it soared 152.44%.
• A 5-year view of Free Cash Flow shows it stood at $89.6 million in 2022, then slumped by 32.83% to $60.2 million in 2023, then jumped by 152.44% to $152.0 million in 2024, then fell by 17.23% to $125.8 million in 2025, then tumbled by 208.18% to -$136.1 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$136.1 million, $125.8 million, and $131.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.